Market Overview:
The global pregnancy-associated plasma protein A (PAPP-A) test kit market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of preterm births, rising awareness about prenatal screening tests, and technological advancements in PAPP-A testing kits. Based on type, the global PAPP-A test kit market is segmented into time-resolved immunofluorescence (TRIF) and chemiluminescence immunoassay (CLIA). TRIF is expected to account for a larger share of the market than CLIA during the forecast period. This can be attributed to its advantages such as high sensitivity and specificity, low cost per test, and easy automation. Based on application, the global PAPP-A test kit market is segmented into hospital laboratories, clinic laboratories, and diagnostic centers. Hospital laboratories are expected to account for a larger share of the market than clinic laboratories during the forecast period.
Product Definition:
A pregnancy-associated plasma protein A (PAPP-A) test kit is a device used to measure the level of PAPP-A in a person's blood. PAPP-A is a protein that is produced by the placenta and can be used to help diagnose pregnancies. The importance of PAPP-A testing may include early detection of Down syndrome and other chromosomal abnormalities.
Time-resolved Immunofluorescence:
Time-resolved immunofluorescence (TRIF) is a technique that allows the study of cell behavior in real time. It is an advanced form of fluorescence microscopy, which provides high temporal and spatial resolution for analyzing biological processes.
Chemiluminescence Immunoassay:
Chemiluminescence immunoassay (CLIA) is a technique used for the detection of specific antigens in the maternal blood. The test helps to determine whether or not the fetus has been infected with certain diseases, such as rubella, cytomegalovirus, toxoplasmosis, and hepatitis B during pregnancy. It also helps detect infections in infants born through placenta Praxbind Test Strip after birth.
Application Insights:
The market is segmented based on application as hospital, clinic, and diagnostic center. The hospital segment dominated the global pregnancy-associated plasma protein A test kit market in 2017 due to a rise in demand for point-of-care tests. Pregnancy is a special situation that requires medical care and attention during its duration. Thus, increasing number of pregnant women across the globe has led to an increase in demand for point-of-care tests at hospitals resulting in high growth rate of this segment over the forecast period.
Clinic segments are expected to witness significant growth over the forecast period owing to rising awareness about early diagnosis and treatment of various diseases during pregnancy among obstetricians/gynecologists along with rising incidences of chronic diseases such as diabetes mellitus among reproductive aged women across regions globally. Rising cases related to preterm birth & low birth weight also stimulate demand for these types of testing at clinics which further drive this segment globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of leading players, availability of advanced products, and high healthcare expenditure in this region. Moreover, increasing prevalence of chronic diseases such as diabetes and obesity is also expected to boost demand for pregnancy-associated plasma protein tests over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising awareness about PAP testing among women and growing target population base due to increased immigration from developed countries. In addition, improving healthcare infrastructure in emerging economies will also support regional market growth during the same period.
Growth Factors:
- Increasing incidence of pre-eclampsia and eclampsia: The increasing incidence of pre-eclampsia and eclampsia is a major growth driver for the pregnancy-associated plasma protein A (PAPP-A) test kit market. According to a study by the World Health Organization, the global prevalence of pre-eclampsia is estimated to be 5–8%. The number of women with pre-eclampsia is on the rise due to various factors such as rising maternal age, obesity, and diabetes. This is expected to drive demand for PAPP-A test kits in the coming years.
- Growing awareness about PAPP-A tests: There has been an increase in awareness about PAPP-A tests in recent years owing to initiatives by various healthcare organizations such as March of Dimes Foundation and American Congress of Obstetricians and Gynecologists (ACOG). This has led more pregnant women to undergo PAPP-A testing, which is expected to boost demand for these kits in the coming years.
- Technological advancements: The development of new technologies that can detect low levels of PAPP‑A has helped improve accuracy levels for these tests. This has resulted in an increase in adoption rates for these tests among pregnant women across different geographies. This trend is likely to continue over the forecast period, driving market growth further..
Scope Of The Report
Report Attributes
Report Details
Report Title
Pregnancy-associated Plasma Protein A Test Kit Market Research Report
By Type
Time-resolved Immunofluorescence, Chemiluminescence Immunoassay
By Application
Hospital, Clinic, Diagnostic Center
By Companies
Bioscience, Daan, Genscript, Easydiagnosis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Pregnancy-associated Plasma Protein A Test Kit Market Report Segments:
The global Pregnancy-associated Plasma Protein A Test Kit market is segmented on the basis of:
Types
Time-resolved Immunofluorescence, Chemiluminescence Immunoassay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Diagnostic Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bioscience
- Daan
- Genscript
- Easydiagnosis
Highlights of The Pregnancy-associated Plasma Protein A Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Time-resolved Immunofluorescence
- Chemiluminescence Immunoassay
- By Application:
- Hospital
- Clinic
- Diagnostic Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pregnancy-associated Plasma Protein A Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pregnancy-associated plasma protein A (PAPP-A) is a blood test that measures the level of PAPP-A in your blood. This test is used to diagnose pregnancy and monitor the health of a pregnant woman.
Some of the major companies in the pregnancy-associated plasma protein a test kit market are Bioscience, Daan, Genscript, Easydiagnosis.
The pregnancy-associated plasma protein a test kit market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pregnancy-associated Plasma Protein A Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pregnancy-associated Plasma Protein A Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pregnancy-associated Plasma Protein A Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pregnancy-associated Plasma Protein A Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pregnancy-associated Plasma Protein A Test Kit Market Size & Forecast, 2020-2028
4.5.1 Pregnancy-associated Plasma Protein A Test Kit Market Size and Y-o-Y Growth
4.5.2 Pregnancy-associated Plasma Protein A Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Time-resolved Immunofluorescence
5.2.2 Chemiluminescence Immunoassay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Diagnostic Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pregnancy-associated Plasma Protein A Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pregnancy-associated Plasma Protein A Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Time-resolved Immunofluorescence
9.6.2 Chemiluminescence Immunoassay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Diagnostic Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Time-resolved Immunofluorescence
10.6.2 Chemiluminescence Immunoassay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Diagnostic Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Time-resolved Immunofluorescence
11.6.2 Chemiluminescence Immunoassay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Diagnostic Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Time-resolved Immunofluorescence
12.6.2 Chemiluminescence Immunoassay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Diagnostic Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Time-resolved Immunofluorescence
13.6.2 Chemiluminescence Immunoassay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Diagnostic Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pregnancy-associated Plasma Protein A Test Kit Market: Competitive Dashboard
14.2 Global Pregnancy-associated Plasma Protein A Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bioscience
14.3.2 Daan
14.3.3 Genscript
14.3.4 Easydiagnosis
